New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2013
07:30 EDTSGENSeattle Genetics downgraded to Hold from Buy at Needham
Needham downgraded Seattle Genetics due to valuation.
News For SGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
10:00 EDTSGENOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:49 EDTSGENSeattle Genetics upgraded to Hold from Sell at Cantor
Subscribe for More Information
October 30, 2014
16:30 EDTSGENSeattle Genetics sees FY14 revenue from ADCETRIS $172M-$177M
Seattle Genetics anticipates that 2014 revenues from ADCETRIS net product sales in the U.S. and Canada will be higher than previously anticipated, and are now expected to be in the range of $172M-$177M. The company also anticipates that 2014 collaboration revenues will be higher than previously anticipated, and are now expected to be in the range of $64M-$68M.
16:30 EDTSGENSeattle Genetics reports Q3 EPS (13c), consensus (24c)
Subscribe for More Information
October 29, 2014
13:09 EDTSGENSeattle Genetics management to meet with Jefferies
Subscribe for More Information
October 27, 2014
10:52 EDTSGENSeattle Genetics, Aegerion CEOs accused of drug use in lawsuit, TheStreet says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use